Dunia de Miguel

598 total citations
18 papers, 268 citations indexed

About

Dunia de Miguel is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Dunia de Miguel has authored 18 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 6 papers in Oncology and 5 papers in Genetics. Recurrent topics in Dunia de Miguel's work include Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Dunia de Miguel is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Dunia de Miguel collaborates with scholars based in Spain, Bangladesh and Greece. Dunia de Miguel's co-authors include Carmen Burgaleta, Julio García‐Suárez, Helena Bañas, Ignacio Arribas, Isabel Krsnik, Teresa Pascual, Jesús M. Cesar, Juan Romanyk, Rosa González and Juan Cuadros‐González and has published in prestigious journals such as Blood, British Journal of Haematology and American Journal of Clinical Pathology.

In The Last Decade

Dunia de Miguel

18 papers receiving 261 citations

Peers

Countries citing papers authored by Dunia de Miguel

Since Specialization

Citations

This map shows the geographic impact of Dunia de Miguel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dunia de Miguel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dunia de Miguel more than expected).

Fields of papers citing papers by Dunia de Miguel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dunia de Miguel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dunia de Miguel. The network helps show where Dunia de Miguel may publish in the future.

Co-authorship network of co-authors of Dunia de Miguel

This figure shows the co-authorship network connecting the top 25 collaborators of Dunia de Miguel. A scholar is included among the top collaborators of Dunia de Miguel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dunia de Miguel. Dunia de Miguel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study 2023 ·Clinical Lymphoma Myeloma & Leukemia ·Enrique M. Ocio, (unknown), Gabriela Bustamante, (unknown), (unknown), Ernesto Pérez Persona, Verónica González‐Calle, (unknown), José-María Arguiñano, Yolanda González, Rafael Ríos, Dunia de Miguel, (unknown), (unknown), (unknown), Laura Rosiñol	1
2	Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndrome 2021 ·Annals of Hematology ·Dolores Subirá, Canan Alhan, Uta Oelschlaegel, Anna Porwit, Katherina Psarra, Theresia M. Westers, (unknown), Lars Nilsson, Arjan A. van de Loosdrecht, Dunia de Miguel	3
3	Clinical and Sociodemographic Characteristics of Patients With Relapsed and/or Refractory Multiple Myeloma and Their influence on Treatment in the Real-World Setting in Spain: The CharisMMa Study 2021 ·Clinical Lymphoma Myeloma & Leukemia ·Enrique M. Ocio, (unknown), Gabriela Bustamante, (unknown), (unknown), Ernesto Pérez Persona, (unknown), (unknown), Yolanda González, Rafael Ríos, Dunia de Miguel, (unknown), (unknown), (unknown), Laura Rosiñol	4
4	Treatment Patterns and Outcomes Among Nontransplant Newly Diagnosed Multiple Myeloma Patients in Spain 2021 ·Future Oncology ·José‐Ángel Hernández‐Rivas, (unknown), (unknown), Araceli Ortíz‐Rubio, (unknown), Dunia de Miguel, (unknown), Dorothy Romanus, (unknown), Courtney Johnson, Shelby Corman, (unknown), Ernesto Pérez Persona	1
5	Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia 2014 ·Leukemia Research ·(unknown), Dunia de Miguel, Alicia Bailén, José R. González, Joan Bargay, José Falantes, Rafael Andreu, Fernando Ramos, Mar Tormo, Salut Brunet, (unknown), (unknown), (unknown), Llorenç Badiella, A. Jurado, Guillermo Sanz	34
6	Multivariate Analysis of the Impact of Pre-Treatment Serum Ferritin Level On Response and Overall Survival in Patients with Myelodysplastic Syndromes Treated with Azacitidine 2012 ·Blood ·(unknown), Dunia de Miguel, Alicia Bailén, José R. González, Joan Bargay, José Falantes, Rafael Andreu, Fernando Ramos, Mar Tormo, Rafael F. Duarte, (unknown), Salut Brunet, Benet Nomdedeu, (unknown), (unknown), Llorenç Badiella, A. Jurado, Guillermo Sanz	3
7	Preliminary Experience of the Spanish Compassionate Use Registry of Bendamustine in Patients with Relapsed and/or Refractory Multiple Myeloma 2012 ·Blood ·Beatriz Aguado, (unknown), (unknown), Felipe de Arriba, (unknown), (unknown), (unknown), Anabel Teruel, (unknown), (unknown), Inmaculada Castillo, Jaime Pérez de Oteyza, Dunia de Miguel, (unknown), (unknown), Adrían Alegre	2
8	Effectiveness of Various Dosage Regimens of Azacitidine In Patients with Myelodysplastic Syndromes: Safety and Efficacy Final Data From the Spanish Azacitidine Compassionate Use Registry 2010 ·Blood ·(unknown), Dunia de Miguel, Joan Bargay, Teresa Bernal, José R. González, Mar Tormo, Fernando Ramos, (unknown), José Falantes, Blanca Xicoy, Guillermo Sanz, (unknown), Salut Brunet, Joaquín Sánchez, (unknown)	3
9	Different Clinical Results with the Use of Different Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndrome Managed in Community-Based Practice: Effectiveness and Safety Data From the Spanish Azacitidine Compassionate Use Registry. 2009 ·Blood ·(unknown), Dunia de Miguel, Alicia Bailén, José R. González, Guillermo Sanz, José Falantes, Rafael Andreu, Mar Tormo, Rafael F. Duarte, (unknown)	7
10	Dose‐adjusted EPOCH plus rituximab is an effective regimen in patients with poor‐prognostic untreated diffuse large B‐cell lymphoma: results from a prospective observational study 2006 ·British Journal of Haematology ·Julio García‐Suárez, Helena Bañas, Ignacio Arribas, Dunia de Miguel, Teresa Pascual, Carmen Burgaleta	33
11	Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature 2005 ·Diagnostic Microbiology and Infectious Disease ·Dunia de Miguel, (unknown), Rosa González, Julio García‐Suárez, Juan Cuadros‐González, (unknown), Juan Romanyk, Carmen Burgaleta	35
12	Platelet Dysfunction in Primary Thrombocythemia Using the Platelet Function Analyzer, PFA-100 2005 ·American Journal of Clinical Pathology ·Jesús M. Cesar, Dunia de Miguel, (unknown), Carmen Burgaleta	24
13	Platelet Dysfunction in Primary Thrombocythemia Using the Platelet Function Analyzer, PFA-100 2005 ·American Journal of Clinical Pathology ·Jesús M. Cesar, Dunia de Miguel, (unknown), Carmen Burgaleta	1
14	Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: Impact of novel therapies 2005 ·American Journal of Hematology ·Julio García‐Suárez, Dunia de Miguel, Isabel Krsnik, Helena Bañas, Ignacio Arribas, Carmen Burgaleta	87
15	Elderly haematological patients with chemotherapy‐induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study of risk‐adapted therapy 2003 ·British Journal of Haematology ·Julio García‐Suárez, Isabel Krsnik, Eduardo Reyes, Dunia de Miguel, (unknown), (unknown), Carmen Burgaleta	10
16	Capillary Whole Blood Testing by a New Portable Monitor: Comparison With Standard Determination of the International Normalized Ratio 2003 ·American Journal of Clinical Pathology ·Dunia de Miguel, Carmen Burgaleta, Eduardo Reyes, Teresa Pascual	3
17	Capillary Whole Blood Testing by a New Portable Monitor 2003 ·American Journal of Clinical Pathology ·Dunia de Miguel, Carmen Burgaleta, Eduardo Reyes, Teresa Pascual	2
18	Spontaneous gas gangrene in malignant lymphoma: An underreported complication? 2002 ·American Journal of Hematology ·Julio García‐Suárez, Dunia de Miguel, Isabel Krsnik, (unknown), (unknown), Carmen Burgaleta	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact